CIRCUMVENT® PCV M G2 has been shown effective for the vaccination of
healthy swine 3 days or 3 weeks of age or older against Porcine
Circovirus Type 2 and Mycoplasma hyopneumoniae. Duration of immunity has
been shown to be at least 20 weeks for Porcine Circovirus Type 2.
Duration of immunity for Mycoplasma hyopneumoniae has not been
established. For more information regarding efficacy and safety data, go
to productdata.aphis.usda.gov. This product has been shown to be
effective against viremia and reduction in viral shedding and lymphoid
infection caused by Porcine Circovirus Type 2 and lung lesions caused by
Mycoplasma hyopneumoniae. Composition: This product contains a subunit
vaccine based on Porcine Circovirus Type 2a.

▪A reliable, one-dose, ready-to-use combo vaccine for PCV2 and
Mycoplasma hyopneumoniae
▪Fight against two costly diseases with one simple, single-bottle
product
▪No mixing, combining or risk of contamination from the process
▪The ONLY PCV2 vaccine that’s approved for use in pigs as early as 3
days of age (two-dose option)
▪Pigs are easiest to pick up by trusted, capable handlers, they are less
likely to be stressed because they are still with their mothers
▪Choose between two convenient options: One dose – single 2 mL
intramuscular dose at three weeks of age or older
▪Aids in the prevention of PCV2 viremia, which is the initial step in
the development of PCV2 disease
▪It’s more effective to control the disease early on so damage caused by
infection is limited or essentially eliminated
▪Microsol Diluvac Forte® adjuvant provides optimal immune response